Editorial
Published on 14 Feb 2023
Editorial: Combining multiple non-invasive images and/or biochemical tests to predict prostate cancer aggressiveness
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1156649
- 927 views
Type at least 3 characters
1,560 articles
Articles
Mini Review
Published on 13 Feb 2023
Monoamine oxidase A: An emerging therapeutic target in prostate cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1137050
- 3,856 views
- 7 citations
Mini Review
Published on 10 Feb 2023
Inhibitor of apoptosis proteins as therapeutic targets in bladder cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1124600
- 3,128 views
- 5 citations
Case Report
Published on 10 Feb 2023
Ultrasonographic manifestations and the effective diagnosis of epididymal leiomyosarcoma: Case report and systematic literature review
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1101801
- 2,358 views
- 1 citation
Original Research
Published on 10 Feb 2023
Surgical strategy of laparoscopic partial nephrectomy: It is more suitable to use transperitoneal approach in anterior tumor patients and retroperitoneal approach in posterior tumor patients
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1115668
- 1,248 views
- 2 citations
Systematic Review
Published on 09 Feb 2023
Dynamic changes in PSA levels predict prognostic outcomes in prostate cancer patients undergoing androgen -deprivation therapy: A multicenter retrospective analysis
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1047388
- 5,214 views
- 5 citations
Editorial
Published on 07 Feb 2023
Editorial: Case reports in urothelial cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1150420
- 1,122 views
Case Report
Published on 07 Feb 2023
Case report: PSMA PET/CT addresses the correct diagnosis in a patient with metastatic prostate cancer despite negative core biopsies and mpMRI. A diagnostic challenge
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1101221
- 1,985 views
- 2 citations
General Commentary
Published on 06 Feb 2023
Commentary: Cancer-testis antigen lactate dehydrogenase C4 as a novel biomarker of male infertility and cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1115620
- 1,013 views
- 1 citation
Review
Published on 03 Feb 2023
The role of immunotherapy in non-clear cell renal cell carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.941835
- 4,808 views
- 8 citations
Original Research
Published on 03 Feb 2023
Clinical and pathological heterogeneity of four common fusion subtypes in Xp11.2 translocation renal cell carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1116648
- 2,179 views
- 4 citations
Original Research
Published on 03 Feb 2023
Syngeneic model of carcinogen-induced tumor mimics basal/squamous, stromal-rich, and neuroendocrine molecular and immunological features of muscle-invasive bladder cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1120329
- 3,198 views
- 4 citations
Original Research
Published on 02 Feb 2023
Prognostic biomarker NEIL3 and its association with immune infiltration in renal clear cell carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1073941
- 2,243 views
- 2 citations
Mini Review
Published on 02 Feb 2023
Geriatric assessment in the older adult with genitourinary cancer: A narrative review
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1124309
- 2,507 views
- 5 citations
Original Research
Published on 02 Feb 2023
Modified anterior approach preserving Retzius space versus standard anterior approach robot-assisted radical prostatectomy: A matched-pair analysis
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1108202
- 1,791 views
- 1 citation
Case Report
Published on 02 Feb 2023
Case Report: Disease progression of renal cell carcinoma containing a novel putative pathogenic KAT6A::NRG1 fusion on Ipilimumab- Nivolumab immunotherapy. A case study and review of the literature
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1111706
- 1,647 views
- 3 citations